##gff-version 3
##sequence-region Q8NCE2 1 650
Q8NCE2	UniProtKB	Chain	1	650	.	.	.	ID=PRO_0000260214;Note=Myotubularin-related protein 14	
Q8NCE2	UniProtKB	Compositional bias	512	518	.	.	.	Note=Poly-Ser	
Q8NCE2	UniProtKB	Active site	330	330	.	.	.	Note=Phosphocysteine intermediate;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q8NCE2	UniProtKB	Modified residue	194	194	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19608861;Dbxref=PMID:19608861	
Q8NCE2	UniProtKB	Modified residue	518	518	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q8NCE2	UniProtKB	Modified residue	530	530	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q8NCE2	UniProtKB	Modified residue	580	580	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18220336;Dbxref=PMID:18220336	
Q8NCE2	UniProtKB	Modified residue	624	624	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q8NCE2	UniProtKB	Modified residue	638	638	.	.	.	Note=Omega-N-methylarginine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
Q8NCE2	UniProtKB	Glycosylation	226	226	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8NCE2	UniProtKB	Glycosylation	519	519	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8NCE2	UniProtKB	Alternative sequence	479	538	.	.	.	ID=VSP_021585;Note=In isoform 3. Missing;Ontology_term=ECO:0000303,ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:14702039,ECO:0000303|PubMed:15489334,ECO:0000303|PubMed:17974005;Dbxref=PMID:14702039,PMID:15489334,PMID:17974005	
Q8NCE2	UniProtKB	Alternative sequence	539	590	.	.	.	ID=VSP_021586;Note=In isoform 2 and isoform 3. Missing;Ontology_term=ECO:0000303,ECO:0000303,ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:14702039,ECO:0000303|PubMed:15489334,ECO:0000303|PubMed:17974005,ECO:0000303|Ref.1;Dbxref=PMID:14702039,PMID:15489334,PMID:17974005	
Q8NCE2	UniProtKB	Natural variant	336	336	.	.	.	ID=VAR_033370;Note=In CNM1%3B may act as a phenotype modifier%3B drastically reduced enzymatic activity. R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17008356;Dbxref=dbSNP:rs121434509,PMID:17008356	
Q8NCE2	UniProtKB	Natural variant	462	462	.	.	.	ID=VAR_033371;Note=In CNM1%3B may act as a disease modifier%3B mutation found in a patient also carrying mutation Lys-368 in DNM2%3B reduced enzymatic activity. Y->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17008356;Dbxref=dbSNP:rs121434510,PMID:17008356	
Q8NCE2	UniProtKB	Mutagenesis	330	330	.	.	.	Note=Drastically reduced enzymatic activity. C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17008356;Dbxref=PMID:17008356	
Q8NCE2	UniProtKB	Sequence conflict	28	28	.	.	.	Note=G->R;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q8NCE2	UniProtKB	Sequence conflict	55	55	.	.	.	Note=E->G;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q8NCE2	UniProtKB	Sequence conflict	126	126	.	.	.	Note=R->G;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q8NCE2	UniProtKB	Sequence conflict	390	390	.	.	.	Note=F->S;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q8NCE2	UniProtKB	Sequence conflict	403	406	.	.	.	Note=EEFS->ALFA;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q8NCE2	UniProtKB	Sequence conflict	554	557	.	.	.	Note=GSWQ->AAGM;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q8NCE2	UniProtKB	Sequence conflict	646	646	.	.	.	Note=S->N;Ontology_term=ECO:0000305;evidence=ECO:0000305	
